ESC Guidelines: Pharmacotherapy for HFrEF (Arabic Version) 

After we learned how to diagnose CHF, now it's time for treatment.
So let's start with prescribing optimal medications for a patient with HFrEF.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
www.escardio.o...
PARADIGM-HF trial, Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
www.nejm.org/d...
TRANSITION Study, NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction.
www.jacc.org/d...
EMPEROR-Reduced trial, Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
www.nejm.org/d...
DAPA-HF trial, Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
www.nejm.org/d...
CHARM-Alternative trial, Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors
www.thelancet....
Val-HeFT trial, A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
www.nejm.org/d...
SHIFT trial, Ivabradine and outcomes in chronic heart failure. A randomised placebo-controlled study
www.thelancet....
VICTORIA trial, Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
www.nejm.org/d...
GALACTIC-HF trial, Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
www.nejm.org/d...